Cite Filings / COAG
Feed Companies Filings Check
Sign in

CIK 0002114044 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Hemab Therapeutics Holdings, Inc.

Sign in to watch
Ticker
COAG
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
414241952
Phone
45 2138 7627
Business address
101 MAIN STREET, SUITE 1220, CAMBRIDGE, MA, 02142
Filings Insiders Search text
All 53 Financials 9 Executive Compensation 6 Insider Trading 22 Beneficial Ownership Interest 10 Business Combinations 6 Public Offerings 5 Others 7
›
Filed in
  1. No filings match these filters. Clear filters
  2. 10-Q Report Quarterly Report 2026-11-10
  3. 8-K Event ● Results of operations 2026-11-10
  4. 8-K Event ● Executive or director change 2026-09-24
  5. 10-Q Report Quarterly Report 2026-08-11
  6. 8-K Event ● Results of operations 2026-08-11
  7. 10-Q Report Quarterly Report 2026-05-21
  8. 8-K Event ● Results of operations 2026-05-21
  9. 8-K Event ● Executive or director change 2026-05-11
  10. 8-K Event Bylaws or fiscal year change · Other events 2026-05-04

Page 1 of 1 · 9 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…